Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — and to fewer overdoses and deaths in people with existing addictions.

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use disorders (SUDs).

Thirty portraits are on display at Hotel Downstreet, part of an initiative to use the arts and storytelling to humanize substance ...

Ryan Paige has called Biddeford home his entire life. He grew up in the city, attended its schools and spent time with ...

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some ...

Medications like Ozempic are drawing new attention from researchers, exploring whether they could help people struggling with ...

Substance use disorder makes it hard to stop using substances even when they're harmful. Using the term "substance use disorder" helps separate the person from the treatable illness. Substance use ...

Project M.O.M. aims to ensure pregnant and postpartum women affected by substance use disorder receive coordinated, ...

Addiction is an umbrella term that reflects qualities of substance use disorder, characterized by an inability to stop using a substance despite harmful consequences. However, addiction is not a ...

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, affecting 12%–13% of adolescents in the United States, according to some studies. The pattern of inattention, ...

A former Brunswick County golf facility has become a recovery center for men and families struggling with substance use and ...